A Randomized Comparison of Immediate Versus Deferred Androgen Deprivation Therapy Using Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms ELAAT
- 31 Aug 2018 Biomarkers information updated
- 08 Jul 2016 Status changed from active, no longer recruiting to completed.
- 05 Jun 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015, according to ClinicalTrials.gov record.